Rochelle Bagatell, M.D.
Rochelle Bagatell, M.D.
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
The Children's Hospital of Philadelphia
Division of Oncology, 4022 CTRB
3501 Civic Center Boulevard
Philadelphia, PA 19104
Division of Oncology, 4022 CTRB
3501 Civic Center Boulevard
Philadelphia, PA 19104
Office: 267-426-9737
Email:
bagatellr@email.chop.edu
bagatellr@email.chop.edu
Education:
M.D.
University of Arizona, 1993.
Permanent linkM.D.
University of Arizona, 1993.
Selected Publications
Macy Margaret E, Duncan Tracey, Whitlock James, Hunger Stephen P, Boklan Jessica, Narendren Aru, Herzog Cynthia, Arceci Robert J, Bagatell Rochelle, Trippett Tanya, Christians Uwe, Rolla Katherine, Ivy S Percy, Gore Lia: A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors. Pediatric blood & cancer 60(2): 230-6, Feb 2013.Park Julie R, Bagatell Rochelle, Hogarty Michael: Children's Oncology Group's 2013 blueprint for research: Neuroblastoma. Pediatric blood & cancer Dec 2012.
Mosse YP, Balis FM, Lim MS, Laliberte J, Voss SD, Fox E, Bagatell R, Weigel B, Adamson PC, Ingle AM, Ahern CH, Blaney S. : Efficacy of Crizotinib in Children with Relapsed/refractory ALK-driven Tumors Including Anaplastic Large Cell Lymphoma and neuroblastoma: A Children's Oncology Group phase I consortium study. . American Society for Clinical Oncology (ASCO) Annual Meeting, Chicago Jun 2012.
Hill-Kayser CE, Tochner Z, Both S, Lustig R, Reilly A, Balamuth N, Womer R, Maris JM, Grupp SA, Bagatell R.: Double Scatter Proton Therapy (DSPT) versus Intensity Modulated X-Ray Therapy (IMRT) for Patients (pts) with High-Risk Neuroblastoma (HRNB). Advances in Neuroblastoma Meeting, Toronto CA Jun 2012.
Bagatell R, Norris RE, Ingle AM, Ahern CH, Saggio J, Little A, Weigel B, Blaney S. : Phase I trial of Temsirolimus (TEM), Irinotecan (IRN), and Temozolomide (TMZ) in Children with Refractory Solid Tumors: A Children's Oncology Group Study. American Society for Clinical Oncology (ASCO) Annual Meeting, Chicago Jun 2012.
Norris R, Shusterman S, Gore L, Macy M, Muscal J, Fox E, Mosse Y, Berkowitz N, Buchbinder A, Bagatell R.: Phase I Trial of Polyethylene Glycol (PEG) Conjugated SN38 in Children with Recurrent or Refractory Neuroblastoma (NB) and Other Solid Tumors. Advances in Neuroblastoma Meeting, Toronto CA Jun 2012.
Park JR, Bagatell R, Berthold F, Brock P, Cohn S, London WB, Pearson A, Siebel N, Matthay KK, Valteau-Couanet D. : Consensus Statement on the Revised International Neuroblastoma Response Criteria. Advances in Neuroblastoma Meeting, Toronto CA Jun 2012.
Johnson K, Mosse Y, Aplenc R, Bagatell R, Balis F, Minturn J, Norris R, Camburn D, Little A, Philips P, Maris J, Fox E. : Disparities in Accrual to Investigational Agent Protocols Among Pediatric Oncology Patients. American Society of Pediatric Hematology-Oncology Meeting, New Orleans LA May 2012.
Wilkens A, Wertheim GBW, Fincher C, Bagatell R, Rheingold SR, Nichols KE, Biegel JA, Conlin L, Deardorff MA: Burkitt Lymphoma in a Child with Mild Pallister-Killian Syndrome. American College of Medical Genetics Annual Clinical Genetics Meeting, Charlotte NC Mar 2012.
Johnson Kelsey A, Aplenc Richard, Bagatell Rochelle: Survival by race among children with extracranial solid tumors in the United States between 1985 and 2005. Pediatric blood & cancer 56(3): 425-31, Mar 2011.